Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro ...

According to data analytics firm IQVIA, over six million units of insulin lispro injection, the type affected by the shortage, were sold over the past three months. Lilly said: 'We recognize that ...

To be effective as of 1st May this year, Lispro will then be the lowest list-priced mealtime insulin available – less than the price of a Humalog vial back in 1999. On which point, Lilly is also ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

The picture shows an ampule of quick-acting insulin lispro taken in Frankfurt ... the lawsuits filed in New Jersey name drug manufacturers Eli Lilly, Novo Nordisk, and Sanofi, along with PBMs ...

Insulin lispro protamine suspension 75% (rDNA origin), insulin lispro 25% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin is the regulation of glucose ...

Eli Lilly said it would institute the cap on ... It is also dropping the list price of its non-branded insulin, Lispro, to $25 a vial, effective 1 May. "While the current healthcare system ...

zinc suspension Humulin L (Lilly) 28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly) 28 days Prescribing information NPH, human insulin isophane suspension ...

Under this agreement, Lilly has been supplying its active pharmaceutical ingredient (API) for insulin to EVA Pharma at a significantly reduced price and providing pro-bono technology transfer to ...